+34 93 363 89 20
Whatsapp
Appointment
           Diagnosis Dermatolgica is a pioneer worldwide center in the diagnosis and treatment of skin cancer
← Home ← TeamDr. Josep Malvehy Guilera
Dr. Josep Malvehy Guilera
Josep Malvehy Guilera

Medical Management in Diagnosis Dermatologica

Collegiate number: 28569

Nrs: E08610550

Catalan Spanish
English French

Prestige and recognitions

Dr. Josep Malvehy is a world leader in research in the diagnosis and treatment of melanoma and skin cancer with extensive experience in this field. He is the director of the cutaneous cancer (melanoma) program of the Hospital Clínic de Barcelona and consultant of the Memorial Sloan Kettering Cancer Center of New York (USA).

He is a consultant to different European and United States governments (NIH) for new technologies and cutaneous cancer treatment. He is currently the leader of the ISIC digital technology group).

Dr. Josep Malvehy is a professor at the American Academy of Dermatology and at the European Academy of Dermatology and Venereology, CILAD, and a member of the Spanish Academy of Dermatology and Venereology.

Member and Spanish representative of the Board of the EADO (European Association of Dermato Oncology) and member of the Melanoma Group of the EORTC and ESMO, the main European oncology organization.

Founding member of the International Dermoscopy Society, the Confocal Working Group and the International Society of teledermatology. He is a full member of the European Academy of Doctors.

Teaching

Professor at the American Academy of Dermatology.

Professor at the European Academy of Dermatology and Venereology.

Director and professor in more than 50 national and international courses in his specialty with more than 4000 students to date.

Academic titles<

Bachelor of Medicine and Surgery from the University of Barcelona.

Doctor of Medicine and specialist in Darmatology.

Associate professor at the University of Barcelona.

Professional experience

More than 25 years of experience.

Director of the Melanoma Unit of the Hospital Clínic de Barcelona.

Specialization

Diagnosis and treatment of skin cancer, confocal microscopy, digital dermatoscopy and biophotonics techniques.

Specialist in melanocytic lesions and in the diagnosis, treatment and genetic research of melanoma.

Dermatological surgery.

Conferences and publications

Author of more than 350 scientific publications in the most prestigious journals in the world in skin cancer and dermatological diagnosis.

Editor of 4 diagnostic books and author of more than 50 book chapters in this field.

Director of 7 world congresses of melanoma and cutaneous cancer and director of the scientific program of more than 20 national and international congresses.

Author of more than 100 national and international scientific conferences.

Scientific director and principal investigator of more than 20 projects in cutaneous cancer and non-invasive diagnosis, biomedicine, biophotonics and other areas.

Director of more than 50 national and international cutaneous cancer courses with more than 4000 students.

Member of private medical associations

Management team and Spanish representative of the European Association of Dermato-Oncology (EADO).

Management team and co-founder of the International Dermoscopy Society.

Management team and co-founder of the International Confocal Working Group.

Management team and co-founder of the International Society of Teledermatology.

Member of the melanoma group of the ESMO (European Society of medical Oncology).

Member of the EORTC melanoma group (European Organization of Research and treatment of cancer).

Member of the European Academy of Doctors.

Professor at the American Academy of Dermatology.

Professor at the European Academy of dermatology and venreology.

Academician of the AEDV (Spanish Academy of Dermatology and venereology).

Recent publications
1.

Improving diagnostic sensitivity of combined dermoscopy and reflectance confocal microscopy imaging through double reader concordance evaluation in telemedicine settings: A retrospective study of 1000 equivocal cases.

Witkowski AM, Łudzik J, Arginelli F, Bassoli S, Benati E, Casari A, De Carvalho N, De Pace B, Farnetani F, Losi A, Manfredini M, Reggiani C, Malvehy J, Pellacani G.

PLoS One. 2017 Nov 9;12(11):e0187748. doi: 10.1371/journal.pone.0187748. eCollection 2017.

2.

Position Statement of the Spanish Academy of Dermatology and Venereology on Teledermatology.

Moreno-Ramírez D, Romero-Aguilera G, Pasquali P, Vaño S, Ríos-Buceta L, Malvehy J, Ferrándiz L; Grupo de e-Dermatología e Imagen de la Academia Española de Dermatología y Venereología.

Actas Dermosifiliogr. 2017 Oct 30. pii: S0001-7310(17)30517-3. doi: 10.1016/j.ad.2017.09.004. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
29096871

Similar articles

3.

Should immediate lymphadenectomy be discontinued in patients with metastasis of a melanoma in the sentinel lymph node? Report of the results of the Multicenter Selective Lymphadenectomy Trial-II.

Moreno-Ramírez D, Vidal-Sicart S, Puig S, Malvehy J.

Med Clin (Barc). 2017 Oct 28. pii: S0025-7753(17)30720-0. doi: 10.1016/j.medcli.2017.08.013. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
29089120

Similar articles

4.

Clinical and dermoscopic characterization of pediatric and childhood melanomas. Multicenter study of 52 cases.

Carrera C, Scope A, Dusza SW, Argenziano G, Nazzaro G, Phan A, Tromme I, Rubegni P, Malvehy J, Puig S, Marghoob AA.

J Am Acad Dermatol. 2017 Oct 9. pii: S0190-9622(17)32475-1. doi: 10.1016/j.jaad.2017.09.065. [Epub ahead of print]

PMID:
29024734

Similar articles

5.

Sentinel lymph node biopsy versus observation in thick melanoma: A multicenter propensity score matching study.

Boada A, Tejera-Vaquerizo A, Ribero S, Puig S, Moreno-Ramírez D, Descalzo-Gallego MA, Fierro MT, Quaglino P, Carrera C, Malvehy J, Vidal-Sicart S, Bennássar A, Rull R, Alos L, Requena C, Bolumar I, Traves V, Pla Á, Fernández-Figueras MT, Ferrándiz C, Pascual I, Manzano JL, Sánchez-Lucas M, Giménez-Xavier P, Ferrandiz L, Nagore E.

Int J Cancer. 2017 Sep 27. doi: 10.1002/ijc.31078. [Epub ahead of print]

PMID:
28960289

Similar articles

6.

Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.

Vallone MG, Tell-Marti G, Potrony M, Rebollo-Morell A, Badenas C, Puig-Butille JA, Gimenez-Xavier P, Carrera C, Malvehy J, Puig S.

Pigment Cell Melanoma Res. 2017 Sep 26. doi: 10.1111/pcmr.12646. [Epub ahead of print]

PMID:
28950052

Similar articles

7.

Ultrasound-based follow-up does not increase survival in early-stage melanoma patients: A comparative cohort study.

Ribero S, Podlipnik S, Osella-Abate S, Sportoletti-Baduel E, Manubens E, Barreiro A, Caliendo V, Chavez-Bourgeois M, Carrera C, Cassoni P, Malvehy J, Fierro MT, Puig S.

Eur J Cancer. 2017 Nov;85:59-66. doi: 10.1016/j.ejca.2017.07.051. Epub 2017 Sep 8.

PMID:
28888850

Similar articles

8.

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.

Ribas A, Dummer R, Puzanov I, VanderWalde A, Andtbacka RHI, Michielin O, Olszanski AJ, Malvehy J, Cebon J, Fernandez E, Kirkwood JM, Gajewski TF, Chen L, Gorski KS, Anderson AA, Diede SJ, Lassman ME, Gansert J, Hodi FS, Long GV.

Cell. 2017 Sep 7;170(6):1109-1119.e10. doi: 10.1016/j.cell.2017.08.027.

PMID:
28886381

Similar articles

9.

A practical guide to the handling and administration of talimogene laherparepvec in Europe.

Harrington KJ, Michielin O, Malvehy J, Pezzani Grüter I, Grove L, Frauchiger AL, Dummer R.

Onco Targets Ther. 2017 Aug 2;10:3867-3880. doi: 10.2147/OTT.S133699. eCollection 2017. Review.

10.

Seven Non-melanoma Features to Rule Out Facial Melanoma.

Tschandl P, Gambardella A, Boespflug A, Deinlein T, de Giorgi V, Kittler H, Lallas A, Malvehy J, Moscarella E, Puig S, Scalvenzi M, Thomas L, Zalaudek I, Alfano R, Argenziano G.

Acta Derm Venereol. 2017 Nov 15;97(10):1219-1224. doi: 10.2340/00015555-2759.

11.

Multispectral imaging system based on light-emitting diodes for the detection of melanomas and basal cell carcinomas: a pilot study (erratum).

Delpueyo X, Vilaseca M, Royo S, Ares M, Rey-Barroso L, Sanabria F, Puig S, Malvehy J, Pellacani G, Noguero F, Solomita G, Bosch T.

J Biomed Opt. 2017 Jul 1;22(7):79801. doi: 10.1117/1.JBO.22.7.079801.

PMID:
28750131

Similar articles

12.

Skin Cancer and the Dermatologist: Reflections on the Position Taken by the Spanish Society of Medical Oncology (SEOM).

Moreno-Ramírez D, Nagore E, Botella-Estrada R, Carretero G, Puig S, Redondo P, Rodrígurez-Prieto MA, Samaniego E, Sanmartín O, Malvehy J.

Actas Dermosifiliogr. 2017 Oct;108(8):704-707. doi: 10.1016/j.ad.2017.06.003. Epub 2017 Jul 10. English, Spanish. No abstract available.

PMID:
28705520

Similar articles

13.

Dermoscopy, Confocal Microscopy and other Non-invasive Tools for the Diagnosis of Non-Melanoma Skin Cancers and Other Skin Conditions.

Malvehy J, Pellacani G.

Acta Derm Venereol. 2017 Jul 5. doi: 10.2340/00015555-2720. [Epub ahead of print]

14.

Efficacy of a Daily Protective Moisturizer with High UVB and UVA Photoprotection in Decreasing Ultraviolet Damage: Evaluation by Reflectance Confocal Microscopy.

Gomes-Neto A, Aguilera P, Prieto L, Seité S, Moyal D, Carrera C, Malvehy J, Puig S.

Acta Derm Venereol. 2017 Nov 15;97(10):1196-1201. doi: 10.2340/00015555-2736.

15.

Amelanotic melanoma in oculocutaneous albinism: a genetic, dermoscopic and reflectance confocal microscopy study.

Ribero S, Carrera C, Tell-Marti G, Pastorino C, Badenas C, Garcia A, Malvehy J, Puig S.

Br J Dermatol. 2017 May 27. doi: 10.1111/bjd.15687. [Epub ahead of print]

PMID:
28555837

Similar articles

16.

Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148.

Fang J, Jia J, Makowski M, Xu M, Wang Z, Zhang T, Hoskins JW, Choi J, Han Y, Zhang M, Thomas J, Kovacs M, Collins I, Dzyadyk M, Thompson A, O'Neill M, Das S, Lan Q, Koster R; PanScan Consortium; TRICL Consortium; GenoMEL Consortium, Stolzenberg-Solomon RS, Kraft P, Wolpin BM, Jansen PWTC, Olson S, McGlynn KA, Kanetsky PA, Chatterjee N, Barrett JH, Dunning AM, Taylor JC, Newton-Bishop JA, Bishop DT, Andresson T, Petersen GM, Amos CI, Iles MM, Nathanson KL, Landi MT, Vermeulen M, Brown KM, Amundadottir LT.

Nat Commun. 2017 May 2;8:15034. doi: 10.1038/ncomms15034.

17.

A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index.

Dirschka T, Pellacani G, Micali G, Malvehy J, Stratigos AJ, Casari A, Schmitz L, Gupta G; Athens AK Study Group.

J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1295-1302. doi: 10.1111/jdv.14267. Epub 2017 May 3.

PMID:
28401585

Similar articles

18.

Dermoscopic Clues for Diagnosing Melanomas That Resemble Seborrheic Keratosis.

Carrera C, Segura S, Aguilera P, Scalvenzi M, Longo C, Barreiro A, Broganelli P, Cavicchini S, Llambrich A, Zaballos P, Thomas L, Malvehy J, Puig S, Zalaudek I.

JAMA Dermatol. 2017 Jun 1;153(6):544-551. doi: 10.1001/jamadermatol.2017.0129.

PMID:
28355453

Similar articles

19.

Patterns of distribution of giant congenital melanocytic nevi (GCMN): The 6B rule.

Martins da Silva VP, Marghoob A, Pigem R, Carrera C, Aguilera P, Puig-Butillé JA, Puig S, Malvehy J.

J Am Acad Dermatol. 2017 Apr;76(4):689-694. doi: 10.1016/j.jaad.2016.05.042.

20.

Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians.

Carrera C, Gual A, Díaz A, Puig-Butillé JA, Noguès S, Vilalta A, Conill C, Rull R, Vilana R, Arguis P, Vidal-Sicart S, Alós L, Palou J, Castel T, Malvehy J, Puig S.

Melanoma Res. 2017 Aug;27(4):315-320. doi: 10.1097/CMR.0000000000000340.

PMID:
28296711

Similar articles



centro dermatológico

cáncer de piel

melanoma

Susana Puig Sarda

Josep Malvehy

diagnosis dermatológica

dermascopia digita

cáncer cutáneo

  • DIAGNOSIS DERMATOLÓGICA (CEDILP)
  • Skin cancer experts
  • Passatge de Ricard Zamora, 1
  • 08017 BARCELONA
  • Collegiate Health Center
  • NRS: E0863749

The information provided on the website does not replace but complements the relationship between the health professional and your patient or visitor and in case of doubt should be consult with your reference health professional.

How to get there by public transport
If you use public transport, you have the following means of transport:

Bus

Line 6 (Sarriá Avenue/Mestre Vila) Line 7 (Diagonal Avenue/Doctor Fleming) Line 33 (Diagonal Avenue/Doctor Fleming) Line 34 (Sarriá Avenue/Mestre Vila) Line 66 (Sarriá Avenue/Mestre Vila) Line 63 (Diagonal Avenue/Doctor Fleming) Line 67 (Diagonal Avenue/Doctor Fleming) Line 78 (Diagonal Avenue/Doctor Fleming) Line 70 (General Mitre/Doctor Fleming) Line H6 (General Mitre/Doctor Fleming) Line N0 (Doctor Fleming/Sarriá Avenue) Line N7 (General Mitre/Sarriá Avenue)

Metro

L3 (green line), Maria Cristina station L3 (green line), Palau Reial station, distant L5 (dark blue line), Hospital Clínic station, distant

Train

TRAM Ferrocarrils L1 L2 L3, L'Illa Diagonal station. FCC Ferrocarrils ES S5 S6 S7 L5 L6, La Bonanova station.
How to get there by private transport
If you use private transport you can choose one of the following accesses:

By car or motorbike

Through Diagonal Avenue and Doctor Fleming street Through Sarria Avenue and Passatge of Ricard Zamora street Through the Ronda de General Mitre and Ricardo Villa street Parking Indigo at Ganduxer 25-27 street (walk access by Dr. Fleming street)
Copyright 2019 DIAGNOSIS DERMATOLÓGICA (CEDILP). All rights reserved.
This website uses its own cookies to collect information in order to improve our services and show information related to your preferences, as well as analyze your browsing habits. If you continue browsing, it means acceptance of the installation of the same. The user has the possibility of configuring his browser allowing, if he wishes, to prevent them from being installed on his hard drive, although he should bear in mind that this action could cause navigation difficulties in some of the pages of this website. It has more information about cookies here . Understood, to accept press